Skip to main content
Clinical Trials/NCT03194594
NCT03194594
Completed
Phase 4

The Effects of Combination of Intravenous Dexamethasone and Ketamine on Change of Postoperative Mood in Patients Undergoing Laparoscopically Assisted Gynecologic Surgery.

Wonkwang University Hospital1 site in 1 country93 target enrollmentMay 2, 2017

Overview

Phase
Phase 4
Intervention
Ketamine Hydrochloride, dexamethasone, and combination of two drugs
Conditions
Depressive Symptoms
Sponsor
Wonkwang University Hospital
Enrollment
93
Locations
1
Primary Endpoint
The change of patient health questionnaire (PHQ)-9 scores
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Ketamine and dexamethasone have been known to be effective postoperative pain. Many studies also have reported these two drugs might change mood such as depression. This study aimed to investigate the effect of each drug individually with their combination on perioperative change of mood in patients undergoing gynecologic surgery

Detailed Description

After receiving by IRB approval and obtaining informed consent from patients, 93 patients who are aged between 18 and 70 years old and classified as American Society of Anesthesiologists (ASA) classes I and II. Afterward, the patients will be randomly (sealed envelopes) allocated into one of three treatment; Group K (n = 31) will receive a single dose of ketamine 0.5 mg/kg i.v. plus 2 ml normal saline, Group D (n = 31) receive dexamethasone 0.5 mg/kg i.v. and a maximum dose of 8 mg plus 2 ml saline, and Group KD (n = 31) receive ketamine 0.5 mg/kg i.v. and dexamethasone 0.5 mg/kg i.v. at 5 minutes after the induction of anesthesia in a double-blinded method.

Registry
clinicaltrials.gov
Start Date
May 2, 2017
End Date
June 12, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Cheol Lee

Chief professor, principal investigator

Wonkwang University Hospital

Eligibility Criteria

Inclusion Criteria

  • patients who were scheduled for laparoscopic gynecologic surgery

Exclusion Criteria

  • Patients with hepatic and renal insufficiency, history of allergy to the study drugs, previous gastric ulcer, diabetes mellitus, and receiving analgesic, antiemetic, antihistamine, steroids or psychiatric drugs within 24 hours before surgery steroids

Arms & Interventions

Group K (n = 31)

will receive a single dose of ketamine 0.5 mg/kg i.v. plus 2 ml normal saline, at 5 minutes after the induction of anesthesia

Intervention: Ketamine Hydrochloride, dexamethasone, and combination of two drugs

Group D (n = 31)

will receive dexamethasone 0.5 mg/kg i.v. plus 2 ml normal saline, at 5 minutes after the induction of anesthesia

Intervention: Ketamine Hydrochloride, dexamethasone, and combination of two drugs

Group KD (n = 31)

will receive ketamine 0.5 mg/kg i.v. and dexamethasone 0.5 mg/kg i.v., at 5 minutes after the induction of anesthesia

Intervention: Ketamine Hydrochloride, dexamethasone, and combination of two drugs

Outcomes

Primary Outcomes

The change of patient health questionnaire (PHQ)-9 scores

Time Frame: at the 1st day after surgery

Anesthesiologist performed the assessment of perioperative depressed mood change with use of Patient Health Questionnaire-9 (PHQ-9). The PHQ-9 is the depression module, which scores each of the nine DSM-IV criteria as "0" (not at all) to "3" (nearly every day) with a total score ranging from 0 to 27; 0-4 none, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe depressed mood

Secondary Outcomes

  • postoperative visual analog scale (VAS) for pain(for 48 h after surgery)
  • patient controlled analgesia (PCA) consumption(for 24 h after surgery)

Study Sites (1)

Loading locations...

Similar Trials